Jared B. J. Milbank

Forma Therapeutics (United States) — United States

Pharmacology, Toxicology and Pharmaceutics · Life Sciences

13h-index1.6kcitations23works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Bioactive Compounds and Antitumor Agents(5), Chemical synthesis and alkaloids(5), Advanced Synthetic Organic Chemistry(5), Monoclonal and Polyclonal Antibodies Research(3), Oxidative Organic Chemistry Reactions(3)

Publications23 total

Quantitative Comparison of Enrichment from DNA-Encoded Chemical Library Selections
ACS Combinatorial Science·2019· 90 citedOpen Access
Novel Methods for Prioritizing “Close-In” Analogs from Structure–Activity Relationship Matrices
Journal of Chemical Information and Modeling·2017· 3 cited
Going Beyond R-Group Tables
ACS symposium series·2016
The Discovery of Potent Nonstructural Protein 5A (NS5A) Inhibitors with a Unique Resistance Profile—Part 1
ChemMedChem·2014· 31 cited
The Discovery of Potent Nonstructural Protein 5A (NS5A) Inhibitors with a Unique Resistance Profile—Part 2
ChemMedChem·2014· 19 cited
A visual analytic study of retracted articles in scientific literature
Journal of the American Society for Information Science and Technology·2012· 73 cited
Synthesis and Evaluation of Stable Bidentate Transition Metal Complexes of 1-(Chloromethyl)-5-hydroxy-3-(5,6,7-trimethoxyindol-2-ylcarbonyl)-2,3-dihydro-1<i>H</i>-pyrrolo[3,2-<i>f</i>]quinoline (<i>seco</i>-6-azaCBI-TMI) as Hypoxia Selective Cytotoxins
Journal of Medicinal Chemistry·2009· 41 cited
Synthesis and SAR comparison of regioisomeric aryl naphthyridines as potent mGlu5 receptor antagonists
Bioorganic & Medicinal Chemistry Letters·2007· 29 citedOpen Access
4-Anilino-5-carboxamido-2-pyridone Derivatives as Noncompetitive Inhibitors of Mitogen-Activated Protein Kinase Kinase
Journal of Medicinal Chemistry·2007· 48 citedOpen Access
Rational design of 7-arylquinolines as non-competitive metabotropic glutamate receptor subtype 5 antagonists
Bioorganic & Medicinal Chemistry Letters·2007· 23 citedOpen Access
ChemInform Abstract: Total Synthesis of (.+‐.)‐Stemonamide and (.+‐.)‐Isostemonamide.
ChemInform·2002
Total synthesis of (±)-stemonamide and (±)-isostemonamide
Tetrahedron·2002· 58 cited
ChemInform Abstract: First Total Synthesis of (.+‐.)‐Stemonamide and (.+‐.)‐Isostemonamide.
ChemInform·2001
Synthesis and Biological Evaluation of Prostaglandin-F Alkylphosphinic Acid Derivatives as Bone Anabolic Agents for the Treatment of Osteoporosis.
Journal of Medicinal Chemistry·2001· 1 cited
Synthesis and Biological Evaluation of Prostaglandin-F Alkylphosphinic Acid Derivatives as Bone Anabolic Agents for the Treatment of Osteoporosis
Journal of Medicinal Chemistry·2001· 16 citedOpen Access
First Total Synthesis of (±)-Stemonamide and (±)-Isostemonamide
Organic Letters·2001· 49 cited
Quinolone signaling in the cell-to-cell communication system of <i>Pseudomonas</i> <i>aeruginosa</i>
Proceedings of the National Academy of Sciences·1999· 1.1k cited
Cytotoxicity and DNA Interaction of the Enantiomers of 6-Amino-3-(chloromethyl)-1-[(5,6,7-trimethoxyindol-2-yl)carbonyl]indoline (Amino-<i>seco</i>-CI-TMI)
Chemical Research in Toxicology·1999· 12 cited
Synthesis of 1-Substituted 3-(Chloromethyl)-6-aminoindoline (6-Amino-<i>seco</i>-CI) DNA Minor Groove Alkylating Agents and Structure−Activity Relationships for Their Cytotoxicity
Journal of Medicinal Chemistry·1999· 33 cited
REDUCTIVE CLAISEN REARRANGEMENTS OF ALLYLOXYANTHRAQUINONES. A REVIEW
Organic Preparations and Procedures International·1997· 10 cited
page 1 of 2Next →

Frequent Co-authors

Andrew S. Kende(6), José Ignacio Martı́n Hernando(4), William A. Denny(4), P. S. RUTLEDGE(4), Moana Tercel(3), William R. Wilson(3), R. C. CAMBIE(3), Thien Duc Tran(2), Florian Wakenhut(2), Chris Pickford(2), Stephen M. Shaw(2), Mike Westby(2), Caroline Smith‐Burchnell(2), Lesa Watson(2), Michael Paradowski(2), Fiona M. Adam(2), Duncan A. Hay(2), Jean‐Yves Chiva(2), Carly L. Nichols(2), David C. Blakemore(2)